Liven Pharma Limited (PSX:LIVEN)
Pakistan
· Delayed Price · Currency is PKR 30.25
-2.43 (-7.44%)
At close: Mar 9, 2026
Liven Pharma Cash Flow Statement
Financials in millions PKR. Fiscal year is July - June.
Millions PKR. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Net Income | -705.64 | -584.46 | 41.74 | -12.33 | -14.29 | -14.63 | Upgrade
|
| Depreciation & Amortization | 31.7 | 27.17 | 24.87 | 13.1 | 14.56 | 16.08 | Upgrade
|
| Other Amortization | 328.27 | 328.27 | 0.69 | - | - | - | Upgrade
|
| Provision & Write-off of Bad Debts | 121.57 | 116.87 | - | - | - | - | Upgrade
|
| Other Operating Activities | 130.58 | 92.58 | 1.15 | -2.9 | -3.22 | -3.55 | Upgrade
|
| Change in Accounts Receivable | -19.98 | -21.52 | -42.29 | - | - | - | Upgrade
|
| Change in Inventory | -3.4 | 0.46 | -11.82 | - | - | - | Upgrade
|
| Change in Accounts Payable | 54.59 | 39.43 | 0.21 | - | -0.07 | -4.16 | Upgrade
|
| Change in Other Net Operating Assets | -0.5 | -0.52 | -0.75 | -0.14 | 0.76 | -0.52 | Upgrade
|
| Operating Cash Flow | 12.69 | -1.72 | 13.8 | -2.27 | -2.26 | -6.79 | Upgrade
|
| Capital Expenditures | -37.68 | -22.84 | - | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -9.41 | -10 | - | - | - | - | Upgrade
|
| Investing Cash Flow | -239.61 | -32.84 | - | - | - | - | Upgrade
|
| Short-Term Debt Issued | - | 168.72 | 11.34 | 2.27 | 2.24 | 6.79 | Upgrade
|
| Long-Term Debt Issued | - | 6.68 | 1.36 | - | - | - | Upgrade
|
| Total Debt Issued | 215.68 | 175.4 | 12.7 | 2.27 | 2.24 | 6.79 | Upgrade
|
| Short-Term Debt Repaid | - | -156.14 | - | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -1.8 | -3.54 | - | - | - | Upgrade
|
| Total Debt Repaid | -7.88 | -157.94 | -3.54 | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | 207.8 | 17.46 | 9.16 | 2.27 | 2.24 | 6.79 | Upgrade
|
| Financing Cash Flow | 207.8 | 17.46 | 9.16 | 2.27 | 2.24 | 6.79 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | -17.32 | 0.03 | - | - | - | - | Upgrade
|
| Net Cash Flow | -36.44 | -17.07 | 22.96 | 0 | -0.02 | -0.01 | Upgrade
|
| Free Cash Flow | -24.98 | -24.56 | 13.8 | -2.27 | -2.26 | -6.79 | Upgrade
|
| Free Cash Flow Margin | -29.53% | -19.30% | 5.63% | - | - | - | Upgrade
|
| Free Cash Flow Per Share | -0.27 | -0.35 | 345.08 | -0.19 | -0.19 | -0.56 | Upgrade
|
| Cash Interest Paid | 1.8 | 0.47 | 0.1 | - | - | - | Upgrade
|
| Levered Free Cash Flow | 148.64 | 151.56 | -163.82 | 3.45 | 4.31 | 0.03 | Upgrade
|
| Unlevered Free Cash Flow | 149.91 | 152.02 | -163.81 | 3.45 | 4.31 | 0.03 | Upgrade
|
| Change in Working Capital | 30.71 | 17.84 | -54.65 | -0.14 | 0.7 | -4.69 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.